Skip to main content

Advertisement

Log in

Anxiety disorders and migraine intractability and progression

  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

Comorbid psychopathology has been implicated as a risk factor for the chronification and progression of migraine. Although past research has focused principally on depression and migraine, recent research consistently has confirmed that a disproportionate number of migraineurs suffer from one or more comorbid anxiety disorders. Moreover, this research has implicated anxiety disorders as factors potentially associated with migraine intractability and progression; growing evidence suggests that anxiety disorders may be even more prognostically significant than depression. This article summarizes these recent developments, considers mechanisms underlying this comorbidity, discusses strategies for assessing and managing comorbid anxiety, and notes directions for future clinical and empiric work.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Lipton RB, Pan J: Is migraine a progressive brain disease? JAMA 2004, 291:493–494.

    Article  PubMed  CAS  Google Scholar 

  2. Lipton RB, Bigal MG: Concepts and mechanisms of migraine chronification. Headache 2008, 48:7–15.

    PubMed  Google Scholar 

  3. Scher AI, Midgette LA, Lipton RB: Risk factors for headache chronification. Headache 2008, 48:16–25.

    PubMed  Google Scholar 

  4. Breslau N: Psychiatric comorbidity in migraine. Cephalalgia 1998, 18(Suppl 22):S56–S61.

    Google Scholar 

  5. Hamelsky SW, Lipton RB: Psychiatric comorbidity of migraine. Headache 2006, 46:1327–1333.

    PubMed  Google Scholar 

  6. Penzien DB, Peatfield RC, Lipchik GL: Headache in patients with co-morbid psychiatric disease. In The Headaches, edn 3. Edited by Olesen J, Goadsby P, Ramadan N, et al.: Philadelphia: Lippincott, Williams & Wilkins; 2006:1117–1124.

    Google Scholar 

  7. Juang KD, Wang SJ, Fuh JL, et al.: Comorbidity of depressive and anxiety disorders in chronic daily headache and its subtypes. Headache 2000, 40:818–823.

    Article  PubMed  CAS  Google Scholar 

  8. Kessler RC, Berglund P, Demler O, et al.: Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005, 62:593–602.

    Article  PubMed  Google Scholar 

  9. Smitherman TA, Penzien DB, Maizels M: Headache chronification: screening and behavioral management of comorbid psychiatric disorders. Headache 2008, 48:45–50.

    PubMed  Google Scholar 

  10. Radat F, Swendsen J: Psychiatric comorbidity in migraine: a review. Cephalalgia 2005, 25:165–178.

    Article  PubMed  CAS  Google Scholar 

  11. Breslau N, Davis GC: Migraine, physical health and psychiatric disorder: a prospective epidemiologic study in young adults. J Psychiatry Res 1993, 27:211–221.

    Article  CAS  Google Scholar 

  12. Breslau N, Davis GC, Andreski P: Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res 1991, 37:11–23.

    Article  PubMed  CAS  Google Scholar 

  13. Breslau N, Schultz LR, Stewart WF, et al.: Headache types and panic disorders: directionality and specificity. Neurology 2001, 56:350–354.

    PubMed  CAS  Google Scholar 

  14. Wang SJ, Juang KD, Fuh JL, Lu SR: Psychiatric comorbidity and suicide risk in adolescents with chronic daily headache. Neurology 2007, 68:1468–1473.

    Article  PubMed  Google Scholar 

  15. Guidetti V, Galli F, Fabrizi P, et al.: Headache and psychiatric comorbidity: clinical aspects and outcome in an 8-year follow-up study. Cephalalgia 1998, 18:455–462.

    Article  PubMed  CAS  Google Scholar 

  16. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, edn 4, text revision. Washington, DC: American Psychiatric Association; 2000.

    Google Scholar 

  17. de Leeuw R, Schmidt JE, Carlson CR: Traumatic stressors and post-traumatic stress disorder symptoms in headache patients. Headache 2005, 45:1365–1374.

    PubMed  Google Scholar 

  18. Pesa J, Lage, MJ: The medical costs of migraine and comorbid anxiety and depression. Headache 2004, 44:562–570.

    Article  PubMed  Google Scholar 

  19. Stewart WF, Lipton RB, Kolodner K, et al.: Reliability of the migraine disability assessment score in a population-based sample of headache sufferers. Cephalalgia 1999, 19:107–114.

    Article  PubMed  CAS  Google Scholar 

  20. Lantéri-Minet M, Radat F, Chautard MH, Lucas C: Anxiety and depression associated with migraine: influence on migraine subjects’ disability and quality of life, and acute migraine management. Pain 2005, 118:319–326.

    Article  PubMed  Google Scholar 

  21. Heckman BD, Holroyd KA: Tension-type headache and psychiatric comorbidity. Curr Pain Headache Rep 2006, 10:439–447.

    Article  PubMed  Google Scholar 

  22. Smitherman TA, Penzien DB, Rains JC: Challenges of nonpharmacologic interventions in chronic tension-type headache. Curr Pain Headache Rep 2007, 11:471–477.

    Article  PubMed  Google Scholar 

  23. Ferrari MD, Saxena PR: On serotonin and migraine: a clinical and pharmacological review. Cephalalgia 1993, 13:151–165.

    Article  PubMed  CAS  Google Scholar 

  24. Hamel E: Serotonin and migraine: biology and clinical implications. Cephalalgia 2007, 27:1295–3000.

    Article  Google Scholar 

  25. Schwedt TJ: Serotonin and migraine: the latest developments. Cephalalgia 2007, 27:1301–1307.

    Article  Google Scholar 

  26. Silberstein SD, Freitag FG, Bigal ME: Migraine treatment. In Wolff’s Headache and Other Head Pain, edn 8. Edited by Silberstein SD, Lipton RB, Dodick DW. New York: Oxford; 2008:177–292.

    Google Scholar 

  27. Lesch KP, Bengel D, Heils A, et al.: Association of anxiety-related traits with a polymorphisms in the serotonin transporter gene regulatory region. Science 1996, 274:1527–1531.

    Article  PubMed  CAS  Google Scholar 

  28. Karwautz AFK, Campos de Sousa S, Wöber C, et al.: Family-based analysis of serotonin transporter gene polymorphisms in migraine with and without aura. Cephalalgia 2007, 27:773–780.

    Article  PubMed  CAS  Google Scholar 

  29. Dodick D, Freitag F: Evidence-based understanding of medication-overuse headache: clinical implications. Headache 2006, 46(Suppl 4):S202–S211.

    Article  PubMed  Google Scholar 

  30. Mathew NT: Transformed migraine. Cephalalgia 1993, 13(Suppl 12):S78–S83.

    Google Scholar 

  31. Mathew NT, Stubits E, Nigam MP: Transformation of episodic migraine into daily headache: analysis of factors. Headache 1982, 22:66–68.

    Article  PubMed  CAS  Google Scholar 

  32. Lake AE III: Medication overuse headache: biobehavioral issues and solutions. Headache 2006, 46(Suppl 3):S88–S97.

    Article  PubMed  Google Scholar 

  33. Radat F, Creac’h C, Swendsen JD, et al.: Psychiatric comorbidity in the evolution from migraine to medication overuse headache. Cephalalgia 2005, 25:519–522.

    Article  PubMed  CAS  Google Scholar 

  34. Radat F, Sakh D, Lutz G, et al.: Psychiatric comorbidity is related to headache induced by chronic substance use in migraineurs. Headache 1999, 39:477–480.

    Article  PubMed  CAS  Google Scholar 

  35. Asmundson GJG, Norton PJ, Norton GR: Beyond pain: the role of fear and avoidance in chronicity. Clin Psychol Rev 1999, 19:97–119.

    Article  PubMed  CAS  Google Scholar 

  36. Nicholson RA, Houle TA, Rhudy JL, Norton, PJ: Psychological risk factors in headache. Headache 2007, 47:413–426.

    PubMed  Google Scholar 

  37. Norton PJ, Asmundson GJG: Anxiety sensitivity, fear, and avoidance behavior in headache pain. Pain 2004, 111:218–223.

    Article  PubMed  Google Scholar 

  38. Barlow DH: Anxiety and Its Disorders, edn 2. New York: Guilford; 2002.

    Google Scholar 

  39. Taylor S (ed): Anxiety Sensitivity: Theory, Research, and Treatment of the Fear of Anxiety. Mahwah, NJ: Erlbaum; 1999.

    Google Scholar 

  40. Asmundson GJG, Norton PJ, Veloso F: Anxiety sensitivity and fear of pain in patients with recurrent headaches. Behav Res Ther 1999, 37:703–713.

    Article  PubMed  CAS  Google Scholar 

  41. Maizels M, Smitherman TA, Penzien DB: A review of screening tools for psychiatric comorbidity in headache patients. Headache 2006, 46(Suppl 3):S98–S109.

    Article  PubMed  Google Scholar 

  42. Kroenke K, Spitzer RL, Williams JBW, et al.: Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med 2007, 146:317–325.

    PubMed  Google Scholar 

  43. Spitzer RL, Kroenke K, Williams JBW, Löwe B: A brief measure for assessing generalized anxiety disorder. Arch Intern Med 2006, 166:1092–1097.

    Article  PubMed  Google Scholar 

  44. Spitzer RL, Kroenke K, Williams JBW, and the Patient Health Questionnaire Primary Care Study Group: Validation and utility of a self-report version of PRIME-MD. JAMA 1999, 282:1737–1744.

    Article  PubMed  CAS  Google Scholar 

  45. Tollison CD, Langley JC: P-3: An Overview of the Pain Patient Profile (TM). Minneapolis, MN: National Computer Systems; 1995.

    Google Scholar 

  46. Antony MM, Rowa K: Evidence-based assessment of anxiety disorders in adults [review]. Psychol Assess 2005, 17:256–266.

    Article  PubMed  Google Scholar 

  47. Lee ST, Park JH, Kim M: Efficacy of the 5-HT1a agonist, buspirone hydrochloride, in migraineurs with anxiety: a randomized, prospective, parallel group, double-blind, placebo-controlled study. Headache 2005, 45:1004–1011.

    Article  PubMed  Google Scholar 

  48. Griffith JL, Razavi M: Pharmacological management of mood and anxiety disorders in headache patients. Headache 2006, 46(Suppl 3):S133–S141.

    Article  PubMed  Google Scholar 

  49. Saper JR, Dodick D, Gladstone JP: Management of chronic daily headache: challenges in clinical practice. Headache 2005, 45(Suppl 1):S74–S85.

    Article  PubMed  Google Scholar 

  50. Rains JC, Penzien DB, Lipchik GL: Behavioral facilitation of medical treatment for headache—part 2: theoretical models and behavioral strategies for improving adherence. Headache 2006, 46:1395–1403.

    PubMed  Google Scholar 

  51. Lipchik GL, Smitherman TA, Penzien DB, Holroyd K: Basic principles and techniques of cognitive-behavioral therapies for comorbid psychiatric symptoms among headache patients. Headache 2006, 46(Suppl 3):S119–S132.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Todd A. Smitherman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Smitherman, T.A., Penzien, D.B. & Maizels, M. Anxiety disorders and migraine intractability and progression. Current Science Inc 12, 224–229 (2008). https://doi.org/10.1007/s11916-008-0039-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11916-008-0039-9

Keywords

Navigation